AURORA, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma announced the appointment of Erik Van Horn, BSCHE to its Board of Directors. Mr. Van Horn is presently employed as a Manufacturing Senior Specialist with Amgen, Inc. Mr. Van Horn is responsible for management of critical manufacturing components in the production of biopharmaceuticals including EPOGEN® and Aranesp®. These prescription drugs are used in the treatment of anemia associated with kidney dialysis or chemotherapy, and are both manufactured under strict FDA compliance guidelines to assure safety and efficacy.
